Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

Nephrology Dialysis Transplantation

Volumn 29, Issue 11, 2014, Pages 2054-2061

  Hoste, Eric A J ^a   McCullough, Peter A ^b,c   Kashani, Kianoush ^d   Chawla, Lakhmir S ^e,f   Joannidis, Michael ^g   Shaw, Andrew D ^h   Feldkamp, Thorsten ^i,j   Uettwiller Geiger, Denise L ^k   McCarthy, Paul ^l   Shi, Jing ^m   Walker, Michael G ^m   Kellum, John A ⁿ  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c The Heart Hospital   (United States)

^d MAYO CLINIC   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j UNIVERSITY OF KIEL   (Germany)

^k Mather Memorial Hospital   (United States)

^l R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^m Walker Bioscience   (United States)

ⁿ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Acute kidney injury; Acute renal failure; Biomarkers; Insulin like growth factor binding protein (IGFBP)7 and tissue inhibitor of metalloproteinases (TIMP) 2; Sensitivity and specificity (MeSH)

Indexed keywords

BIOLOGICAL MARKER; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; TIMP2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL DECISION MAKING; COHORT ANALYSIS; CRITICALLY ILL PATIENT; CUTOFF; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; UNITED STATES; URINE LEVEL; CELL CYCLE CHECKPOINT; CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; URINE;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; CELL CYCLE CHECKPOINTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84919790228     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu292     Document Type: Article

References (34)

1. Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006;10:R73
2. Murugan R, Karajala-Subramanyam V, Lee M et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010;77:527-535
3. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012;380:756-766
4. Lameire NH, Bagga A, Cruz D et al. Acute kidney injury: an increasing global concern. Lancet 2013;382:170-179
5. Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009;119:2444-2453
6. Bihorac A, Yavas S, Subbiah S et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009;249:851-858
7. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138
8. Kashani K, Al-Khafaji A, Ardiles T et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25
9. Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003;49:1-6
10. Palevsky PM, Molitoris BA, Okusa MD et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 2012;7:844-850
11. Cruz DN, Bagshaw SM, Maisel A et al. Use of biomarkers to assess prognosis and guide management for patients with acute kidney injury. Contrib Nephrol 2013;182:45-64
12. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford: Oxford University Press, 2003
13. Joannidis M, Metnitz B, Bauer P et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009;35:1692-1702
14. The R Project for Statistical Computing. www. R-project.org (1 September 2004, date last accessed)
15. Zhou Xh, McClish DK, Obuchowski NA. Statistical Methods in Diagnostic Medicine. 2nd edn. Hoboken: Wiley, 2011
16. Agresti A. Categorical Data Analysis. Hoben, NJ: Wiley, 2002
17. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr. et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172
18. Kundu S, Aulchenko YS, van Duijn CM et al. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol 2011;26:261-264
19. Robin X, Turck N, Hainard A et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845
21. NCEPOD. Adding insult to injury 2009. http://www.ncepod.org.uk/2009aki.htm (1 September 2004, date last accessed)
22. Balasubramanian G, Al-Aly Z, Moiz A et al. Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study. Am J Kidney Dis 2011;57:228-234
23. Colpaert K, Hoste EA, Steurbaut K et al. Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med 2012;40:1164-1170
24. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167
25. Keller T, Zeller T, Ojeda F et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-2693
26. Januzzi JL, Jr, Bamberg F, Lee H et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010;121:1227-1234
27. Bihorac A, Chawla LS, Shaw AD et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014;189:932-939
28. Brienza N, Giglio MT, Marucci M et al. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009;37:2079-2090
29. Brar SS, Aharonian V, Mansukhani P et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 2014;383:1814-1823
30. Goldstein SL, Kirkendall E, Nguyen H et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 2013;132:756-767
31. Perner A, Haase N, Guttormsen AB et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-134
32. Hirschberg R, Kopple J, Lipsett P et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patient with acute renal failure. Kidney Int 1999;55:2423-2432
33. Siew ED, Matheny ME, Ikizler TA et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 2010;77:536-542
34. Sapphire investigators. http://www.ccm.pitt.edu/sapphire-investigators (1 September 2004, date last accessed)